Search

Issue
Title
Authors
Vol 26, No 1 (2024)
Safety and efficacy of ribociclib in combination with letrozole in an extended population of patients with HR+/HER2- advanced breast cancer: analysis of data from a subgroup of patients from Russia in the phase lllb CompLEEment-1 study
Zhukova L.G., Bolotina L.V., Dvornichenko V.V., Fadeeva N.V., Ganshina I.P., Grechukhina K.S., Hasanova A.I., Kislov N.V., Kudryavtsev I.Y., Manikhas A.G., Musaeva N.E., Nizhegorodtseva A.A., Sadikova O.E., Sakaeva D.D., Snegovoy A.V., Stroyakovskiy D.L., Tjulandin S.A., Trishkina E.A., Vladimirova L.I., Volkov N.M., Kostalanova Y.V.
PDF
(Rus)
Vol 24, No 2 (2022)
Current treatment aspects of hormone-dependent ERBB2-negative metastatic breast cancer: overall survival outcomes
Snegovoy A.V., Kononenko I.B.
PDF
(Rus)
Vol 24, No 1 (2022)
Management of patients with hormone receptor-positive HER2-negative metastatic breast cancer: data of randomized trials and real-world evidence
Editorial B.
PDF
(Rus)
Vol 25, No 1 (2023)
Following in the footsteps of SABCS 2022: top 12 advanced breast cancer studies that could change our clinical practice: A review
Kolyadina I.V.
PDF
(Rus)
Vol 26, No 1 (2024)
Efficacy and safety of alpelisib in patients with HR+HER2-negative metastatic breast cancer in real clinical practice: Results of a single-center observational retrospective study
Sultanbaev A.V., Kolyadina I.V., Menshikov K.V., Musin S.I., Nasretdinov A.F., Sultanbaeva N.I., Rakhimov R.R., Lipatov D.O., Menshikova I.A., Izmailov A.A., Lipatova E.E.
PDF
(Rus)
Vol 25, No 4 (2023)
Ribociclib + adjuvant hormone therapy in early breast cancer: prevention of recurrence. New opportunities. A review
Ognerubov N.A.
PDF
(Rus)
Vol 23, No 4 (2021)
Innovations in practice. 5 years of palbociclib experience in the Russian Federation. Overview of web-conference took place on 8 October 2021
Editorial B.
PDF
(Rus)
Vol 23, No 1 (2021)
Analysis of the efficacy and safety of eribulin therapy in patients with HR+/HER2- metastatic breast cancer pretreated with CDK4/6 inhibitors in real Russian practice
Kolyadina I.V., Abidova N.R., Akopyan A.A., Antonova G.V., Arapova O.I., Bobrova E.A., Bolotina L.V., Valiakhmetova C.K., Vasilevskaya A.V., Vladimirova L.Y., Volkonskiy M.V., Ganshina I.P., Gudkova I.E., Dergunov A.S., Evstigneeva I.V., Egurenkova V.S., Emshanov A.V., Zhukova L.G., Zueva E.V., Karabina E.V., Kolokolov J.J., Kuzmicheva S.V., Kuchevskaya O.A., Luev I.A., Maistrenko K.S., Markizova E.V., Marfutov V.V., Medvedev S.P., Merzlikina Y.I., Nersesova T.A., Ovchinnikova E.G., Orlova S.A., Samaneva N.Y., Stativko O.A., Storozhakova A.E., Stroyakovskiy D.L., Sultanbaev A.V., Tekeeva A.I., Fadeeva N.V., Fedorova A.N., Shalaeva O.M., Shangina I.A., Shirokova O.N., Shumskikh A.R., Yakubova M.Z.
PDF
(Rus) PDF
(Eng)
Vol 23, No 3 (2021)
Place of CDK 4/6 and PARP inhibitors in the modern treatment approach of HER2-negative breast cancer
Editorial B.
PDF
(Rus)
Vol 23, No 1 (2021)
Don’t let it disappear: new opportunities to prolong the life of HR+ HER2- advanced breast cancer patients. Event review of the satellite symposium. RUSSCO Big Conference «Breast Cancer» (online). January 28th, 2021
Board E.
PDF
(Rus)
Vol 20, No 2 (2018)
Ribociclib in 1st line HR+ breast cancer treatment
Zhukova L.G., Ganshina I.P., Gordeeva O.O., Lubennikova E.V.
PDF
(Rus)
Vol 22, No 2 (2020)
Prospects of eribulin administration for patients with HR-positive HER2-negative metastatic breast cancer after progression on CDK4/6 Inhibitors: theoretical background and first experience
Kolyadina I.V., Ganshina I.P., Kuzmicheva S.V., Tekeeva A.I., Kolokolov J.D., Volkonskii M.V., Poddubnaya I.V.
PDF
(Rus) PDF
(Eng)
1 - 12 of 12 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies